IL48785A - Pharmaceutical preparations containing a beta-receptor blocking compound and a compound regulating the thrombocyte function and, optionally, an alpha-receptor blocking compound, for the treatment of coronary heart diseases - Google Patents

Pharmaceutical preparations containing a beta-receptor blocking compound and a compound regulating the thrombocyte function and, optionally, an alpha-receptor blocking compound, for the treatment of coronary heart diseases

Info

Publication number
IL48785A
IL48785A IL48785A IL4878576A IL48785A IL 48785 A IL48785 A IL 48785A IL 48785 A IL48785 A IL 48785A IL 4878576 A IL4878576 A IL 4878576A IL 48785 A IL48785 A IL 48785A
Authority
IL
Israel
Prior art keywords
compound
receptor blocking
blocking compound
beta
alpha
Prior art date
Application number
IL48785A
Other languages
English (en)
Other versions
IL48785A0 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL48785A0 publication Critical patent/IL48785A0/xx
Publication of IL48785A publication Critical patent/IL48785A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL48785A 1975-01-06 1976-01-05 Pharmaceutical preparations containing a beta-receptor blocking compound and a compound regulating the thrombocyte function and, optionally, an alpha-receptor blocking compound, for the treatment of coronary heart diseases IL48785A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH7175 1975-01-06

Publications (2)

Publication Number Publication Date
IL48785A0 IL48785A0 (en) 1976-03-31
IL48785A true IL48785A (en) 1978-08-31

Family

ID=4178628

Family Applications (1)

Application Number Title Priority Date Filing Date
IL48785A IL48785A (en) 1975-01-06 1976-01-05 Pharmaceutical preparations containing a beta-receptor blocking compound and a compound regulating the thrombocyte function and, optionally, an alpha-receptor blocking compound, for the treatment of coronary heart diseases

Country Status (14)

Country Link
JP (1) JPS5191337A (ko)
AU (1) AU499140B2 (ko)
BE (1) BE837293A (ko)
CA (1) CA1063516A (ko)
DE (1) DE2600069A1 (ko)
FR (1) FR2296430A1 (ko)
GB (1) GB1510370A (ko)
HK (1) HK49680A (ko)
IE (1) IE42766B1 (ko)
IL (1) IL48785A (ko)
MY (1) MY8100159A (ko)
NL (1) NL7600045A (ko)
NZ (1) NZ179623A (ko)
ZA (2) ZA7628B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019006A1 (de) * 1979-05-14 1980-11-26 Ciba-Geigy Ag Pharmazeutische Präparate, die als Wirkstoff ein substituiertes Pyrazolidinderivat enthalten, deren Verwendung und Verfahren zu ihrer Herstellung
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
TW284688B (ko) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL37700A (en) * 1970-10-02 1975-05-22 Ciba Geigy Ag Pharmaceutical preparations containing an aryloxypropanolamine derivative or an arylethanolamine derivative

Also Published As

Publication number Publication date
ZA7626B (en) 1976-12-29
GB1510370A (en) 1978-05-10
CA1063516A (en) 1979-10-02
AU1000276A (en) 1977-07-14
IE42766L (en) 1976-07-06
BE837293A (fr) 1976-07-05
NZ179623A (en) 1978-03-06
FR2296430A1 (fr) 1976-07-30
MY8100159A (en) 1981-12-31
JPS5191337A (ko) 1976-08-10
AU499140B2 (en) 1979-04-05
ZA7628B (en) 1976-12-29
HK49680A (en) 1980-09-12
DE2600069A1 (de) 1976-07-15
IE42766B1 (en) 1980-10-08
IL48785A0 (en) 1976-03-31
FR2296430B1 (ko) 1978-11-10
NL7600045A (nl) 1976-07-08

Similar Documents

Publication Publication Date Title
JPS5233399A (en) Patient*s respirator
NL190448B (nl) Geneesmiddel dat furocoumarine derivaten bevat voor fotochemische therapie.
AU1285476A (en) Human heart valve
GB1540441A (en) Treatment of blood plasma
JPS5495575A (en) Hydantoin derivative therapeutic medicine
EG12353A (en) Derivatives of alcoyloxy-5-phenyl-1-3-oxidiazoline-1,3,4 one-2,their preparation and their use as insecticides and acaricides
JPS5246689A (en) Heart pacemaker checking system
NO152414C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2,6-dialkoksybenzamider
AU498717B2 (en) Zirconium alloy heat treatment
IL48785A (en) Pharmaceutical preparations containing a beta-receptor blocking compound and a compound regulating the thrombocyte function and, optionally, an alpha-receptor blocking compound, for the treatment of coronary heart diseases
JPS5254286A (en) Heart pacemaker
NO154795C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1,2,4-oxadiazolin-5-on-derivater.
KE3645A (en) A process for the manufacture of novel benzazole derivatives,pharmaceutical preparations containing these derivatives,and their use
IL48787A0 (en) Pharmaceutical preparations comprising phentolamine,for the treatment of circulatory disorders
ZA763081B (en) Pharmaceutical preparations for the treatment of hyperuricacidemia
NO147108C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 1-amino-lavere-alkyl-3,4-difenyl-1h-pyrazoler
GB1541501A (en) Implantable heart pacemaker
NO144883C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2-difenyl-3-(imidazolyl-1)-propener
NO153652C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1,2,4-oxadiazin-derivater.
PH12349A (en) Treatment of seedlings
AU506773B2 (en) Compositions for treatment of cardiac rhythm disturbance
JPS5271898A (en) Improvement of blood dialyzer
NO149889C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte 1-piperazinyl-4h-s-triazolo(3,4c)tieno(2,3e)-1,4-diazepiner
NO147755C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-n-substituerte derivater av fortimicin-b
NO801129L (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt n,n`-difenylhydrazinderivat